Skip to main content
. 2018 Sep 10;19(9):2688. doi: 10.3390/ijms19092688
ABC Activated B-cell-like
ALCL Anaplastic Large-Cell Lymphoma
ALL Acute Lymphoblastic Leukemia
AML Acute Myeloid Leukemia
BL Burkitt Lymphoma
B-LBL B-cell Lymphoblastic Lymphoma
cALL Childhood ALL
CML Chronic Myeloid Leukemia
CNS Central nervous System
CYT Cytarabin
DAUNO Daunorrubicin
DEXA Dexamethasone
DFS Disease-Free Survival
DLBCL Diffuse Large B-cell lymphoma
eBL Endemic Burkitt Lymphoma
EBNA1 Epstein–Barr nuclear antigen 1
EBV Epstein–Barr virus
EFS Event-Free Survival
GCB Germinal center B cell-like
HL Hodgkin Lymphoma
INZ Inauhzin
JMML Juvenile Myelomonocytic Leukemia
l-ASP l-asparaginase
LDH Lactate dehydrogenase
LL Lymphoblastic Lymphoma
miR Micro RNA
MiRNAs Micro RNAs
MTX Methotrexate
NHL Non-Hodgkin Lymphoma
OS Overall Survival
PMLBCL Primary Mediastinal Large B Cell Lymphoma
PRED Prednisone
PREDS Prednisolone
RFS Relapse-Free Survival
RT-PCR Reverse Transcription Polymerase Chain Reaction
T-LBL T-cell Lymphoblastic Lymphoma
VIN Vincristine
WHO World Health Organization